Emory University researchers have provided the first proof of concept in a nonhuman primate model for eliminating ...

Naglaa Shoukry and Petronela Ancuta, researchers in the Immunopathology Research Theme at the Centre de recherche du CHUM (CRCHUM), are shedding new light on one of the greatest challenges in HIV ...

Dolutegravir/lamivudine shows comparable virologic suppression to bictegravir/emtricitabine/tenofovir alafenamide in HIV with very high viral loads, with no significant difference between the regimens ...

HIV is famously hard to defeat because it hides. Standard treatment can drive the virus down to undetectable levels, but it lurks in a dormant reservoir that roars back the moment therapy stops, which ...

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...

A new once-weekly HIV pill matched daily treatment in a Phase 3 trial, offering a potentially simpler option for people with ...

Emory University researchers have provided the first proof-of-concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved medication for cancer.

Postdoctoral researcher Archana Joon at Albert Einstein College of Medicine studies how herpes simplex virus reshapes the ...

For years, Pakistan has seen cases of children infected with HIV due to unsafe treatment in clinics and hospitals. A current ...

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...